8-K/A: UnitedHealth Group Amends Executive Compensation Details for New Officer
Executive Compensation Update
UnitedHealth Group has amended its previous 8-K filing to detail the compensation package for a new officer, including base salary, cash incentives, and stock awards.
Summary
- UnitedHealth Group filed an amendment to its original 8-K report from March 28, 2024.
- The amendment details the compensation package for Mr. Rex, which was approved by the Compensation and Human Resources Committee.
- Mr. Rex will receive an annual base salary of $1,400,000.
- He is also eligible for an annual cash incentive award with a target value of 200% of his base salary.
- Additionally, Mr. Rex will receive stock awards including stock options valued at $150,000, restricted stock units valued at $150,000, and performance shares valued at $300,000.
Sentiment
Score: 7
Explanation: The document is a routine update on executive compensation, which is generally neutral to positive. The details are clear and transparent, which is a positive sign for investors.
Positives
- The compensation package for Mr. Rex is clearly defined, providing transparency to investors.
- The inclusion of performance-based incentives aligns management interests with shareholder value.
Industry Context
Executive compensation packages are a standard practice in the healthcare industry, and this filing provides insight into UnitedHealth Group's approach to attracting and retaining talent.
Comparison to Industry Standards
- Executive compensation packages in large healthcare companies like UnitedHealth Group typically include a mix of base salary, cash incentives, and equity awards.
- The specific values of these components can vary based on the executive's role, experience, and company performance.
- Companies like CVS Health, Cigna, and Humana also use similar compensation structures to attract and retain top talent.
- The mix of stock options, restricted stock units, and performance shares is a common practice to align executive interests with long-term shareholder value.
Stakeholder Impact
- Shareholders will be interested in the details of executive compensation as it relates to company performance and alignment of interests.
- Employees may be interested in the compensation structure as it relates to their own potential for advancement and rewards.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Date of the original 8-K report. |
| April 17, 2024 | Date of the amended 8-K/A report. |
Keywords
executive compensation, stock options, restricted stock units, performance shares, cash incentive, base salary, UnitedHealth Group, officer compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.